MDM2 and liposarcoma: In solid tumors, responses have generally been modest, with the most compelling benefit seen in well-/dedifferentiated liposarcoma (WD/DD-LPS), where MDM2 amplification on chromosome 12q15 is nearly universal and frequently co-occurs with CDK4 amplification (Traweek et al., 2022).